Liver cancer, the third leading cause of death worldwide, is a silent killer that strikes unexpectedly—difficult to detect in its early stages, and often diagnosed at an advanced stage. But recent research has uncovered an unexpected "behind-the-scenes culprit": the gut microbiota may be quietly influencing liver health.

Tumor-infiltrating lymphocytes (TILs) therapy is an adoptive immune cell therapy that collects lymphocytes infiltrating around tumor cells from the cancer patient's own tumor biopsy tissue, amplifies and cultures them in vitro, and then infuses them back into the patient's body.

肝癌